Dragon Life Science Holdings Group, Inc.
NOHO · OTC
8/31/2021 | 8/31/2020 | 8/31/2019 | 8/31/2018 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $213 | $1 | $2 | $4 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $213 | $1 | $2 | $4 |
| Operating Income | -$213 | -$1 | -$2 | -$4 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$51 | -$43 | -$139 | $0 |
| Pre-Tax Income | -$264 | -$44 | -$140 | -$4 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$264 | -$44 | -$140 | -$4 |
| % Margin | – | – | – | – |
| EPS | 0 | 0 | -0 | -0 |
| % Growth | – | 100% | -3,646.8% | – |
| EPS Diluted | 0 | 0 | -0 | -0 |
| Weighted Avg Shares Out | 11,854,767 | 8,574,146 | 8,574,146 | 8,574,146 |
| Weighted Avg Shares Out Dil | 11,854,767 | 8,574,146 | 8,574,146 | 8,574,146 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $51 | $43 | $139 | $0 |
| Depreciation & Amortization | $237 | $206 | $172 | $0 |
| EBITDA | $24 | -$1 | -$2 | -$4 |
| % Margin | – | – | – | – |